Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
04 Sep 2017 Ribociclib Receives EU Approval as First-Line Treatment for HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
04 Sep 2017 ESMO 2017 Press Release: ICON8 Trial Reaffirms Standard Dosing in Ovarian Cancer Chemo Gynaecologic malignancies
03 Sep 2017 ESMO 2017 Press Release: Study in Early Stage Breast Cancer Shows That Even Small Tumours Can Be Aggressive Breast cancer
02 Sep 2017 ESMO 2017 Press Release: Study Highlights Overuse of Tumour Marker Tests in Primary and Secondary Care Epidemiology/Etiology/Cancer Prevention
01 Sep 2017 FDA Approves Tisagenlecleucel for B-Cell ALL and Tocilizumab for Cytokine Release Syndrome Haematologic malignancies - Palliative and supportive care - Cancer Immunology and Immunotherapy
01 Sep 2017 ESMO 2017 Media Alert: Updated ESMO Magnitude of Clinical Benefit Scale Set to Evaluate Single-arm Studies
31 Aug 2017 Indels Provide Highly Immunogenic Neoantigens and May Be Potential Biomarkers of Immunotherapy Response Translational research - Cancer Immunology and Immunotherapy
31 Aug 2017 ESMO 2017 Press Release: IFCT-0302 results question role of CT-scan in NSCLC post-surgery follow-up Lung and other thoracic tumours
30 Aug 2017 NICE Issues Technology Appraisal Guidance on Olaratumab in Combination with Doxorubicin for Treating Advanced STS Sarcomas - Anticancer agents & Biologic therapy
30 Aug 2017 Media Alert: ESMO 2017 Poster and Oral Abstracts Published Online Tonight
29 Aug 2017 Adolescent and Young Adult Cancer Survivors Are Less Likely to Have HPV-Vaccination than Peers Cancer in Special Situations - Epidemiology/Etiology/Cancer Prevention
23 Aug 2017 Concept Paper on Development and Lifecycle of Personalised Medicines and Companion Diagnostics Personalised medicine - Bioethics, legal and economic issues
22 Aug 2017 FDA Approves Inotuzumab Ozogamicin for Relapsed or Refractory B-Cell Precursor ALL Haematologic malignancies - Anticancer agents & Biologic therapy
21 Aug 2017 FDA Expands Ibrutinib Indications to Chronic GVHD Cancer in Special Situations - Haematologic malignancies - Anticancer agents & Biologic therapy
18 Aug 2017 FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy